9.200
−8,91%
2026-10-15
Fundamental Analysis
41 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -20.7% | +326.1% | 2 / 3 | -32.5% | +2.41 pp | -12.75 pp | +49.7% | 9.01 | 5.53 | 31,4 | −32,5% | −9,0 | −21,8% | 5.53 | 5.56 | −0,5% |
| Pts | 0 | 12 | 8 | 0 | 8 | 0 | 12 | -4 | 8 | |||||||
Valuation annotation:Price: 9.200 (close price on 2026-10-15)EPS (TTM): 1.663
Financial charts
1.Revenue & growth
VND bn31,4Q2/26
1.Revenue & growth
VND bn31,4Q2/26
2.Profit & growth
VND bn-9,35Q2/26
3.Profit mix (Penman)
VND bn31,2Q2/26
4.Margins & cost structure
%66.8%Q2/26
5.Returns & cash cycle
% · days11.5%Q2/26
6.Earnings quality & cash
VND bn31,6Q2/26
7.Asset structure
VND bn960Q2/26
8.Funding & debt health
VND bn · times960Q2/26
9.Revenue backlog
VND bn0,20Q2/26
10.Valuation
times · %5,6×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %-584Q2/26
Adjusted EPS growth, latest quarter
No comparable quarter a year earlier
Average adjusted EPS growth, 3 quarters
500%
averaged over 2 quarter(s)
Quarters at 25%+ growth
1/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26